Unknown PHASE4 INTERVENTIONAL 1-arm NCT02545972

Once-a-day Tacrolimus Conversion Study: The OneTAC Trial (OneTAC)

A Prospective Non-randomized Trial of Conversion From Twice a Day Tacrolimus to Once Daily Modified Release Tacrolimus

Sponsor: Newark Beth Israel Medical Center

Interventions tacrolimus extended release

Updated 7 times since 2017 Last updated: Sep 20, 2016 Started: Feb 29, 2016 Primary completion: Nov 30, 2018 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart Failure, this trial is ongoing. The trial is conducted by Newark Beth Israel Medical Center and has accumulated 7 data snapshots since 2016. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Mar 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Newark Beth Israel Medical Center

Data source: Newark Beth Israel Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Newark, United States